(Q42844140)

8 November 2017

title

FGF23 or PTH: which comes first in CKD ? (English)

1 reference

8 November 2017

1

Tamara Isakova

1 reference

8 November 2017

Myles S Wolf

2

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 November 2010

1 reference

8 November 2017

1 reference

8 November 2017

volume

78

1 reference

8 November 2017

issue

10

1 reference

8 November 2017

page(s)

947-949

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2010.281

8 November 2017

exact match

0 references

cites work

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.281

7 January 2021

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.281

7 January 2021

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.281

7 January 2021

Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.281

7 January 2021

Klotho in chronic kidney disease--what's new?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.281

7 January 2021

Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.281

7 January 2021

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.281

7 January 2021

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.281

7 January 2021

Identifiers

DOI

10.1038/KI.2010.281

1 reference

8 November 2017

1 reference